Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
GLP-1 medications create a different rhythm for hunger
The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035
Tirzepatide functions as an imbalanced dual agonist, characterised by a molecular structure exhibiting a markedly higher affinity for the GIP receptor than the GLP-1 receptor
Excess weight loss (EWL) of at least 50% and remission of comorbidities are considered a success post MBS
:max_bytes(150000):strip_icc()/VWH-GettyImages-2059065209-7ab09bdd0be8409493ace4364fccf792.jpg)
US$ 25.22
US$ 21.67
US$ 26.23
US$ 20.87
US$ 25.03
US$ 29.00
US$ 24.46
US$ 23.02
US$ 26.23
